How Statins Could be Evaluated Successfully in Clinical Trials for Alzheimer’s Disease
American Journal of Alzheimer's Disease and Other Dementias, 04/23/2012Burgos JS et al.
The authors consider that there are a number of explanations for this failure that may provide guidance for selecting and clinically developing statins with therapeutic efficacy in Alzheimer’s disease (AD).
Over the last decade, a large number of experimental observations have suggested a relationship between alterations in cholesterol homeostasis and Alzheimer’s disease (AD).
Moreover, epidemiological studies have pointed an association between statin treatment and a decrease in the risk of having AD.
For these reasons, a large number of clinical trials have been carried out to determine whether the statins can prevent the progression of AD.
However, these studies did not provide clear evidence for the therapeutic efficacy in AD.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.